Biolife solutions to provide third quarter 2023 financial results and business update on november 9, 2023

Bothell, wash. , nov. 2, 2023 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("cgt") and broader biopharma markets, today announced the company's third quarter financial results will be released after market close on thursday, november 9, 2023.
BLFS Ratings Summary
BLFS Quant Ranking